Skip to main content
SpringerLink
Log in
Book cover

26. Hämophilie-Symposion 1995 pp 98–102Cite as

Blutungen bei systemischer fibrinolytischer Therapie im Kindesalter

  • Conference paper

  • 30 Accesses

Zusammenfassung

Eine der schwerwiegendsten Komplikationen einer fibrinolytischen Therapie ist die intrazerebrale Blutung. Bei Erwachsenen mit fibrinolytischer Therapie wegen eines Myokardinfarktes liegt die Hirnblutungsinzidenz zwischen 0,3 und 5% [25]. Als Risikofaktoren für die Entwicklung einer intrazerebralen Blutung als Folge einer fibrinolytischen Therapie wegen eines Myokardinfarktes wurden zunehmendes Alter, Hypertonie bei stationärer Aufnahme sowie niedriges Körpergewicht beschrieben. Des weiteren zeigte sich, daß die Verwendung von rt-PA mit einer höheren Inzidenz intrazerebraler Blutungen assoziiert ist als die von Streptokinase [7,14,30].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aydogan U, Cantez T, Dindar A, Tanman B, Ertugrul T, Omeroglu R (1992) Fibrinolytic therapy for femoral arterial thrombosis after cardiac catheterization in infants and children. J Invas Cardiol 4:445–447

    Google Scholar 

  2. Breviere GM, Vaksmann G, Francart C, Rey C, Dupuis C (1989) Traitement par l’Urokinase des thromboses arterielles systemiques du nouveau-ne. Arch Mal Coeur 82:771–777

    PubMed  CAS  Google Scholar 

  3. Brun P, Beaufils F, Pillon G, Schlegel N, Loirat C (1993) Thrombose des veins renales du nouveau-ne: traitement et prognostic a long terme. Ann Pediatr Paris 40:75–80

    PubMed  CAS  Google Scholar 

  4. Brus F, Witsenburg M, Hofhuis WJD, Hazelzet JA, Hess J (1990) Streptokinase treatment for femoral artery thrombosis after arterial cardiac catheterization in infants and children. Br Heart J 63:291–294

    Article  PubMed  CAS  Google Scholar 

  5. Diekmann L (1980) Streptokinase- und Heparinbehandlung beim hämolytisch-urämischen Syndrom. Klin Pädiat 192:430–435

    Article  CAS  Google Scholar 

  6. Gildwein HP, Wildberg A, Sutor AH, Mocellin R. Hochdosierte Streptokinase- oder Urokinasebehandlung arterieller Thrombosen nach Katheteruntersuchungen. 23. Jahrestagung der Deutsch. Gesellschaft für Pädiatrische Kardiologie 7. und 8.10.1991 Mainz, Abstract P23

    Google Scholar 

  7. GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:673–682

    Google Scholar 

  8. Ino T, Benson LN, Freedom RM, Barker GA, Aipurski A, Rowe RD (1988) Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization. Am Heart J 115:633–639

    Article  PubMed  CAS  Google Scholar 

  9. Kirk CR, Qureshi SA (1989) Streptokinase in the management of arterial thrombosis in infancy. Int J Cardiol 25:15–20

    Article  PubMed  CAS  Google Scholar 

  10. Klinge J, Ries M, Hofbeck M, Singer H, Scharf J (1995) Therapy of thrombosis in childhood with low dose rt-PA - expirience in 20 children. Thromb Haemost 73:1329

    Google Scholar 

  11. Krogmann ON, Kries R, Schreiber R et al. (1990) Thrombosen bei herzkranken Kindern und deren Behandlung. In: Sutor H (Hrsg) Thrombosen im Kindesalter. Editiones Roche, Basel, S 47–54

    Google Scholar 

  12. Levy M, Benson LN, Burrows PE et al. (1991) Tissue Plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 118:467–472

    Article  PubMed  CAS  Google Scholar 

  13. Loirat C, Beaufils F, Sonsino N, Schlegel N, Guesnu M, Pillion G, Andre JL, Broyer M, Guyot C, Habib R, Mathieu H (1984) Traitement du Syndrome hemolytique et uremique de Penfant par Purokinase. Arch Fr Pediatr 41:15–19

    PubMed  CAS  Google Scholar 

  14. Maggioni AP, Franzosi MG, Santoro E, White H, Van deWerf F, Tognoni G, the Gruppo Italiano per 10 Studio della Soprawivenza nelP Infarto Miocardico II (GISSI-2), and the International Study Group (1992) The risk of stroke in patients with acute myocardial infarction after thrombolytic treatment. N Engl J Med 327:1–6

    Article  PubMed  CAS  Google Scholar 

  15. Marraro G, Uderzo C, Riva A, Bonanomi E, Masera G (1991) Use of Urokinase in the treatment of pulmonary thromboembolism in oncohaematologic children. Haematologica 76 [Suppl 4]: 19

    Google Scholar 

  16. Ment LR (1994) Intraventricular hemorrhage of the preterm infant. In: Oski FA, DeAngelis CD, Feigin RD, McMillan JA, Warshaw JB (eds) Principles and practice of pediatrics. Lippincott, Philadelphia, pp 347–352

    Google Scholar 

  17. Monnens L, VanCollenburg J, Dejong M, Zoethout H, VanWieringen P (1978) Treatment of the hemolytic-uremic Syndrome. Helv Paediat Acta 33:321–328

    PubMed  CAS  Google Scholar 

  18. Nitschman E, Leaker MT, Benson L, Mitchell LG, Andrew M (1995) Thrombolytic therapy in pediatric patients. Thromb Haemost 73:948

    Google Scholar 

  19. Nowak-Göttl U, Schwabe D, Schneider W, Schlösser R, Kreuz W (1992) Thrombolysis with recombinant tissue-type Plasminogen activator in renal venous thrombosis in infancy. Lancet 340:1105

    Article  PubMed  Google Scholar 

  20. Nowak-Göttl U, Kreuz WD, Schwabe D, Linde R, Kornhuber B (1991) Thrombolyse mit rt-PA bei Kindern mit arteriellen und venösen Thrombosen - ein neuer Therapieansatz. Klin Pädiatr 203:359–362

    Article  PubMed  Google Scholar 

  21. Powell HR, Ekert H (1974) Streptokinase and anti-thrombotic therapy in the hemolyticuremic Syndrome. J Pediatr 84:345–349

    Article  PubMed  CAS  Google Scholar 

  22. Reidy SJ, O’Hara PA, O’Brien P (1989) Streptokinase use in children undergoing cardiac catheterization. J Cardiovasc Nurs 4:46–56

    PubMed  CAS  Google Scholar 

  23. Ross P, Ehrenkranz R, Kleinman CS, Seashore JH (1989) Thrombus associated with central venous catheters in infants and children. J Pediatr Surg 24:253–256

    Article  PubMed  Google Scholar 

  24. Schreiber R, Schuhmacher G, Bühlmeyer K (1984) Systemische Fibrinolyse-Therapie Katheterbedingter arterieller und venöser Gefäßverschlüsse im Kindesalter. In: Schreiber R (Hrsg) Hämostase bei kardialen und vaskulären Erkrankungen. Müller & Steinicke, München, S 93–99

    Google Scholar 

  25. Simoons ML, Maggioni AP, Knatterud G, Leimberger JD, Jaegere P de, Domburg R van, Boersma E, Franzosi MG, Califf R, Schröder R, Braunwald E (1993) Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet 342:1523–1528

    Article  PubMed  CAS  Google Scholar 

  26. Strife JL, Ball WS, Towbin R, Keller MS, Dillon T (1988) Arterial occlusions in neonates: use of fibrinolytic therapy. Radiology 166:395–400

    PubMed  CAS  Google Scholar 

  27. Stuart J, Winterborn MH, White RHR, Flinn RM (1974) Thrombolytic therapy in Haemolytic-Uraemic Syndrome. BMJ 3:217–221

    Article  PubMed  CAS  Google Scholar 

  28. Sutor AH, Künzer W (1977) Zur Problematik der Streptokinase-Dosierung im Kindesalter. Monatsschr Kinderheilkd 125:533–534

    PubMed  CAS  Google Scholar 

  29. Suzuki A, Tetsuro K, Ono Y, Kinoshita Y (1993) Thrombolysis in the treatment of patients with Kawasaki disease. Cardiol Young 3:207–215

    Article  Google Scholar 

  30. Third International Study of Infarct Survival Collaborative Group: ISIS 3 (1992) A randomised comparison of Streptokinase vs tissue Plasminogen activator vs anistreplase andof aspirin plus heparin vs aspirin alone among 41299 cases of suspected acute myocardial infarction. Lancet 339:753-770

    Google Scholar 

  31. Wessel DL, Keane JF, Fellows KE, Robichaud H, Lock JE (1986) Fibrinolytic therapy for femoral arterial thrombosis after cardiac catheterization in infants and children. Am J Cardiol 58:347–351

    Article  PubMed  CAS  Google Scholar 

  32. Wever MLG, Liem KD, Geven WB, Tanke RB (1995) Urokinase therapy in neonates with catheter related central venous thrombosis. Thromb Haemost 73:180–185

    PubMed  CAS  Google Scholar 

  33. Zenz W, Muntean W, Beitzke A, Zobel G, Riccabona M, Gamillscheg A (1993) Tissue Plasminogen activator treatment (alteplase) for femoral artery thrombosis after cardiac catheterisation in infants and children. Br Heart J 70:382–385

    Article  PubMed  CAS  Google Scholar 

  34. Zenz W, Muntean W, Zobel G, Beitzke (1994) Recombinant tissue Plasminogen activator in thrombotic disease in childhood. Ann Hematol 69: S8

    Google Scholar 

Download references

Authors
  1. W. Zenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Sodia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Berghold
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Zenz, W., Sodia, S., Berghold, A. (1997). Blutungen bei systemischer fibrinolytischer Therapie im Kindesalter. In: 26. Hämophilie-Symposion 1995. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60418-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60418-8_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61101-1

  • Online ISBN: 978-3-642-60418-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation